A nationwide population-based cohort study in South Korea compared the effectiveness of omega-3 fatty acids and fenofibrate for reducing major adverse cardiovascular events (MACE) in individuals with metabolic syndrome (≥30 years) on statin therapy.1
A challenging aspect of glycaemic control presents in patients diagnosed with early-onset type 2 diabetes mellitus (T2DM). Considering this challenge, how can effective management of glycaemic control be achieved in patients with uncontrolled T2DM who are hesitant to incorporate multiple oral antidiabetic drugs into their current regimen? In this case study, Dr Matthew Tan shared his clinical experience in managing a young adult patient with T2DM using GLYXAMBI®, a fixed-dose combination of empagliflozin and linagliptin taken once daily. He demonstrated how applying the G.R.A.C.E. concept to the treatment improved the patient’s clinical outcome.
This advertorial is sponsored as an educational programme by Boehringer Ingelheim Singapore Pte. Ltd.
Limited data exists on COVID-19 mRNA vaccine
effectiveness in children aged 1–4 years, particularly against Omicron
subvariants. In a cohort study conducted during Omicron XBB subvariant
predominant period in Singapore, completing the primary COVID-19 mRNA vaccine
series significantly protected against COVID-19 infection in this age group,
with 45.2% and 63.3% vaccine effectiveness in partially and fully vaccinated
children, respectively. Vaccine effectiveness was also robust at 74.6% in
children with prior COVID-19 infection who received at least one vaccine dose.
During the launch of Nicorette® QuickMist at the Kuala Lumpur Nicotine Addiction International Conference (KLNAC) 2023, a panel of distinguished experts led the discussion on the role of Nicotine Replacement Therapy (NRT) on smoking cessation management. The panel comprised of notable experts, including Professor Chris Bullen (New Zealand), Associate Professor Dr Amer Siddiq bin Amer Nordin (Malaysia), Dr Philip Tønnesen (Denmark) and Professor Philip Eng (Singapore).
Dr. Chan Kwok Wai Adrian, Prof. Yang Kuang-Yao, 20240110000000
At the 27th Congress of the Asian Pacific Society of Respirology (APSR) 2023, a Pfizer-sponsored symposium addressed the evolving challenges of COVID-19, particularly for patients with pre-existing respiratory conditions. Chaired by Dr Chan Kwok Wai Adrian, a renowned respiratory physician and intensivist from Mount Elizabeth Novena Hospital, Singapore, and featuring insights from Professor Yang Kuang-Yao of National Yang Ming Chiao Tung University, Taipei, Taiwan, the symposium focused on the disease’s impact, treatment guidelines, regional management strategies, and the role of nirmatrelvir/ritonavir, a new oral combination pill, in the treatment of COVID-19.
Assoc Prof. Carolina García-Vidal, Dr. Jasmine Chung, 20240106000000
At a recent symposium organized by Pfizer, in collaboration with the Society of Infectious Disease Singapore, A/Prof Carolina García-Vidal, Senior Specialist, Infectious Diseases Department at Hospital Clínic de Barcelona, Spain, shared valuable insights on managing invasive fungal infections (IFIs) in nontraditional hosts. The session was chaired by Dr Jasmine Chung, Senior Consultant and Director of the Antimicrobial Stewardship Unit, Singapore General Hospital.
The 25th World Congress of Dermatology (WCD), jointly organised by the International League of Dermatological Societies (ILDS) and WCD, took place in Singapore from 3 to 8 July 2023. As part of this esteemed event, a sponsored symposium, featured three distinguished speakers who shared their insights concerning pigmentary disorders (PD) and the role of dermocosmetics in the management of post inflammatory hyperpigmentation (PIH). The session was chaired by Professor Thierry Passeron.
Patients with immune-mediated inflammatory diseases face increased COVID-19 risks, but mRNA vaccines offer crucial protection against severe outcomes, including hospitalisation and death, as highlighted by real-world data.